Literature DB >> 12802289

Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers.

M J Ferber1, D P Montoya, C Yu, I Aderca, A McGee, E C Thorland, D M Nagorney, B S Gostout, L J Burgart, L Boix, J Bruix, B J McMahon, T H Cheung, T K H Chung, Y F Wong, D I Smith, L R Roberts.   

Abstract

Chronic infections with the hepatitis B virus (HBV) and high-risk human papillomaviruses (HPVs) are important risk factors for hepatocellular carcinoma (HCC) and cervical cancer (CC), respectively. HBV and HPV are DNA viruses that almost invariably integrate into the host genome in invasive tumors. The viral integration sites occur throughout the genome, leading to the presumption that there are no preferred sites of integration. A number of viral integrations have been shown to occur within the vicinity of important cancer-related genes. In studies of HBV-induced HCC and HPV-induced CC, we have identified two HBV and three HPV integrations into the human telomerase reverse transcriptase (hTERT) gene. Detailed characterization of the integrations revealed that four integrations occurred within the hTERT promoter and upstream region and the fifth integration occurred in intron 3 of the hTERT gene. None of the integrations altered the hTERT coding sequence and all resulted in juxtaposition of viral enhancers near hTERT, with potential activation of hTERT expression. Our work supports the hypothesis that the sites of oncogenic viral integration are nonrandom and that genes at the sites of viral integration may play important roles in carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12802289     DOI: 10.1038/sj.onc.1206528

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  66 in total

Review 1.  Update of research and management of hepatitis B.

Authors:  Takeshi Okanoue; Masahito Minami
Journal:  J Gastroenterol       Date:  2006-02       Impact factor: 7.527

2.  Hepatocellular carcinoma (HCC) recurring 10 years after clearance of hepatitis B surface antigen and 20 years after resection of hepatitis B virus-related HCC.

Authors:  Hiroji Shinkawa; Takuya Nakai; Akihiro Tamori; Hiromu Tanaka; Shigekazu Takemura; Kazuki Ohba; Takahiro Uenishi; Masao Ogawa; Satoshi Yamamoto; Seikan Hai; Tsuyoshi Ichikawa; Shintaro Kodai; Kazuhiro Hirohashi; Kenichi Wakasa; Shoji Kubo
Journal:  Int J Clin Oncol       Date:  2008-12-18       Impact factor: 3.402

3.  Difference in hTERT gene expressions between HbsAg-positive and HbsAg-negative hepatocellular carcinoma.

Authors:  Yueqing Guo; Xu Zhou; Enyu Liu; Xingrui Li; Jinwen Liu; Zhifang Yang; Jilin Yi
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

4.  HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress.

Authors:  Vonetta M Williams; Maria Filippova; Ubaldo Soto; Penelope J Duerksen-Hughes
Journal:  Future Virol       Date:  2011-01-01       Impact factor: 1.831

Review 5.  New issues in the pathogenesis of hepatocellular carcinoma: Applying insights from next-generation DNA sequencing technologies to improve therapy for hepatocellular carcinoma.

Authors:  Roongruedee Chaiteerakij; Lewis R Roberts
Journal:  Clin Liver Dis (Hoboken)       Date:  2013-01-23

6.  VirusSeq: software to identify viruses and their integration sites using next-generation sequencing of human cancer tissue.

Authors:  Yunxin Chen; Hui Yao; Erika J Thompson; Nizar M Tannir; John N Weinstein; Xiaoping Su
Journal:  Bioinformatics       Date:  2012-11-17       Impact factor: 6.937

Review 7.  A second chance for telomerase reverse transcriptase in anticancer immunotherapy.

Authors:  Maurizio Zanetti
Journal:  Nat Rev Clin Oncol       Date:  2016-06-01       Impact factor: 66.675

8.  Biology of SNU cell lines.

Authors:  Ja-Lok Ku; Jae-Gahb Park
Journal:  Cancer Res Treat       Date:  2005-02-28       Impact factor: 4.679

Review 9.  Viruses associated with human cancer.

Authors:  Margaret E McLaughlin-Drubin; Karl Munger
Journal:  Biochim Biophys Acta       Date:  2007-12-23

Review 10.  Molecular targeted therapies in hepatocellular carcinoma.

Authors:  Josep M Llovet; Jordi Bruix
Journal:  Hepatology       Date:  2008-10       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.